Abbott (NYSE: ABT) and BG Medicine, Inc. announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott’s ARCHITECT immunochemistry instrument platform, specifically the company’s i1000SR and i2000SR instruments. The agreement grants Abbott a [...]

Pregnant women appear to have worse clinical and economic outcomes after thyroid and parathyroid surgery compared with women who are not pregnant, according to a report in the May issue of Archives of Surgery, one of the JAMA/Archives journals.

Boston Scientific Corporation (NYSE: BSX) announced the schedule of the Company’s major events and news announcements at the 58th Annual Scientific Session of the American College of Cardiology / i2 Summit, which runs from March 28-31 in Orlando, Florida.

I-Flow Corporation (NASDAQ:IFLO), through its wholly-owned subsidiary AcryMed Inc., announced that it received 510(k) clearance on February 26, 2009 from the Food and Drug Administration (FDA) for its stabilized antimicrobial wound gel. The product, as yet unnamed, has been FDA cleared for both over-the-counter and prescription-only marketing and distribution.

A groundbreaking study is launched today in 24 countries across Europe to understand how certain chronic health conditions affect people’s ability to work and make contributions to society. The study will also consider the impact on public welfare systems of supporting significant numbers of people who are unable to participate in labour markets.